M&A Deal Summary

Charles River Laboratories International Acquires CiToxLAB Group

On February 13, 2019, Charles River Laboratories International acquired life science company CiToxLAB Group from Ardian for 448M EUR

Acquisition Highlights
  • This is Charles River Laboratories International’s 20th transaction in the Life Science sector.
  • This is Charles River Laboratories International’s 4th largest (disclosed) transaction.
  • This is Charles River Laboratories International’s 1st transaction in France.

M&A Deal Summary

Date 2019-02-13
Target CiToxLAB Group
Sector Life Science
Buyer(s) Charles River Laboratories International
Sellers(s) Ardian
Deal Type Add-on Acquisition
Deal Value 448M EUR
Advisor(s) Goodwin Procter (Legal)

Target

CiToxLAB Group

Cedex, France
website
CiToxLAB Group is a provider of non-clinical contract research organization (CRO), specializing in regulated safety assessment services, non-regulated discovery services, and medical device testing. CiToxLAB Group was founded in 1969 and is based in Cedex, France.

Search 192,510 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Charles River Laboratories International

Wilmington, Massachusetts, United States

website


Category Company
Founded 1947
Sector Life Science
Employees18,600
Revenue 3.5B USD (2021)
DESCRIPTION

Charles River Laboratories International is a provider of essential products and contract services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Charles River Laboratories International was incorporated in 1947 and is based in Wilmington, Massachusetts.


DEAL STATS #
Overall 23 of 31
Sector (Life Science) 20 of 28
Type (Add-on Acquisition) 18 of 26
Country (France) 1 of 1
Year (2019) 1 of 2
Size (of disclosed) 4 of 17
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-02-13 MPI Research

Mattawan, Michigan, United States

MPI Research, Inc. is a premier non-clinical contract research organization (CRO) providing comprehensive testing services to biopharmaceutical and medical device companies worldwide. MPI Research was founded in 1995 and is based in Mattawan, Michigan.

Buy $800M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-12-16 HemaCare

Northridge, California, United States

HemaCare Corp. is a provider in the customization of human-derived biological products and services for biomedical research, drug discovery, process development, and cell and gene therapy starting material. HemaCare Corp. was founded in 1978 and is headquartered in Northridge, California.

Buy $380M

Seller(S) 1

SELLER

Ardian

Mountain View, California, United States

website


Category Company
Founded 2003
Sector Healthcare Services
DESCRIPTION

Ardian, Inc. is a developer of catheter-based therapies to treat hypertension and related conditions. Ardian is the eighth company created by The Foundry, a leading medical device incubator.


DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (France) 1 of 1
Year (2019) 1 of 1